Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Immunology|September 14, 2020
Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin SystemPascal Urwyler, Stephan Moser, Panteleimon Charitos, et al.
Frontiers in Medicine|September 19, 2025
Effects of a community pharmacy-based structured medication review on drug-related problems in all-comers with polypharmacy: a randomized, controlled, double-blind, parallel-group trialThorsten Bischof, Alexander Schmidt-Ilsinger, Magdalena Hoppel, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort StudySeverin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, et al.
European Journal of Gastroenterology & Hepatology|November 10, 2017
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver diseaseStephan Moser, Karin Kozbial, Hermann Laferl, et al.
Trials|January 5, 2021
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)Pascal Urwyler, Panteleimon Charitos, Stephan Moser, et al.
Frontiers in Immunology|November 15, 2023
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trialPascal Urwyler, Marina Leimbacher, Panteleimon Charitos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 15, 2017
Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatmentKarin Kozbial, Stephan Moser, Ramona Al-Zoairy, et al.
Pageof 2